About SemaglutideEdge
SemaglutideEdge was built for the millions of Americans navigating GLP-1 medications without a clear, independent guide.
When semaglutide prescriptions surged past 30 million in the US, the internet filled with conflicting information — pharma-funded content, outdated advice, and articles written by people who had never taken these medications. SemaglutideEdge exists to fix that.
What we do
We publish evidence-based guides on semaglutide, Ozempic, Wegovy, Mounjaro, Zepbound, and all GLP-1 medications — covering everything from getting a prescription affordably, to managing side effects, building a sustainable diet, and choosing the right telehealth program.
Every article is researched using peer-reviewed sources, FDA guidance, and real user experiences from the GLP-1 community. We update our content regularly as guidelines, pricing, and programs change.
Who runs this site
SemaglutideEdge is run by Robert, a health researcher and web developer with over 15 years of experience in digital publishing. This site has no affiliation with any pharmaceutical company, telehealth provider, or insurance company.
When we recommend a product or program, we say so clearly, explain why, and disclose any affiliate relationship transparently.
Our editorial standards
- All health claims are linked to primary sources — CDC, NIH, FDA, and PubMed
- We disclose all affiliate relationships at the top of every relevant article
- Content is reviewed for factual accuracy before publication
- Articles are updated when medical guidelines, drug availability, or pricing changes
- We never accept payment to write positive reviews
What we cover
- Semaglutide and GLP-1 medication guides for beginners
- Side effect management — nausea, fatigue, hair loss, constipation and more
- Meal plans, food lists, and diet guides for GLP-1 users
- Telehealth program reviews and cost comparisons
- Ozempic, Wegovy, Mounjaro, and Zepbound news and updates
Our mission
To be the most trusted independent resource for Americans navigating GLP-1 weight loss medications in 2026 and beyond — with no pharma sponsorship, no hidden agendas, and no medical jargon.
Get in touch
Have a question, spotted an error, or want to discuss a partnership? We’d love to hear from you. Contact us here.